TaiRx, Inc. (TPEX:6580)
15.55
-2.40 (-13.37%)
Apr 20, 2026, 1:19 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 1.99 billion as of April 17, 2026. Its market cap has decreased by -35.71% in one year.
Market Cap
1.99B
Enterprise Value
1.66B
Revenue
27.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.55
Market Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 1.99B, a decrease of -38.88%. That is a compound annual growth rate of -5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.99B | -18.04% |
| Dec 31, 2025 | 2.42B | -15.03% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomics BioSci & Tech. | 2.59B |
| GlycoNex Incorporation | 2.58B |
| 3D Global Biotech | 2.50B |
| G&E Herbal Biotechnology | 2.38B |
| Chunghwa Chemical Synthesis & Biotech | 2.28B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.16B |
| Sunny Pharmtech | 2.13B |
| Synbio Tech | 2.04B |